Pharma Germany warns of spreading dangerous diseases in Germany

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Pharma Germany warns of the dangers of tropical pathogens and the increasing advance of the tiger mosquito in southern Germany. The article emphasizes the need for prevention and innovation in health care and appeals to politics to promote framework conditions for vaccine development and treatment of tropical diseases. Learn more about Pharma Germany and the importance of prevention measures and vaccinations.

Pharma Deutschland warnt vor den Gefahren tropischer Krankheitserreger und dem zunehmenden Vordringen der Tigermücke in Süddeutschland. Der Artikel betont die Notwendigkeit von Prävention und Innovation in der Gesundheitsversorgung und appelliert an die Politik, Rahmenbedingungen für Impfstoffentwicklung und Behandlung von Tropenkrankheiten zu fördern. Erfahren Sie mehr über Pharma Deutschland und die Bedeutung von Präventionsmaßnahmen und Impfungen.
Pharma Germany warns of the dangers of tropical pathogens and the increasing advance of the tiger mosquito in southern Germany. The article emphasizes the need for prevention and innovation in health care and appeals to politics to promote framework conditions for vaccine development and treatment of tropical diseases. Learn more about Pharma Germany and the importance of prevention measures and vaccinations.

Pharma Germany warns of spreading dangerous diseases in Germany

Climate change and travel: new challenges for health care

Climate change and increasing travel are new challenges for health care. Pharma Germany warns of the penetration of the tiger mosquito in southern Germany and the spread of diseases such as Lyme disease and early summer meningoencephalitis (TBE). The association emphasizes the importance of prevention and innovation in health care.

The tiger mosquito, a potential carrier of dengue and chikungunya fever, has already established itself in parts of southern Germany. At the same time, the TBE risk areas spread further, and even the first cases of oropouche fever were diagnosed with returnees from Cuba. It is worrying that most of the TBE sufferers were not sufficiently vaccinated.

Dr. Elmar Kroth, Managing Director of Science at Pharma Germany, appeals to politics to create framework conditions that promote the development of vaccines and treatment methods for tropical diseases. New approaches are urgently needed, especially for diseases such as borreliosis, against which there is no vaccination or a specific active ingredient. The history of malaria in Central Europe shows that changes in the environment and society can have an impact on the spread of diseases.

In view of the current situation, prevention measures must be increased and innovative research approaches have to be implemented. The pharmaceutical industry is ready to make its contribution and to use your know-how in the development of pharmaceuticals and vaccines against life-threatening diseases.

Pharma Germany calls on politics to take measures to promote innovations in health care. The spread of tropical pathogens in Germany is already a reality and requires comprehensive preparation for the health system.

The topic of health care faces new challenges due to climate change and travel. It is important to strengthen prevention and develop innovative solutions to deal with these challenges.



Pharma Germany e.V.

Pharma Deutschland e.V. is the largest industry association in the pharmaceutical industry in Germany. The association represents around 400 member companies that employ around 80,000 employees in Germany. The companies are significantly involved in the supply of pharmaceuticals and provide a large part of the over -the -counter and prescription medication.
You can find more information at www.pharmadeutschland.de.